163 related articles for article (PubMed ID: 35944462)
1. Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma.
Yang SC; Wang WY; Zhou JJ; Wu L; Zhang MJ; Yang QC; Deng WW; Sun ZJ
Int Immunopharmacol; 2022 Oct; 111():109113. PubMed ID: 35944462
[TBL] [Abstract][Full Text] [Related]
2. VISTA blockade alleviates immunosuppression of MDSCs in oral squamous cell carcinoma.
Liu J; Lin WP; Xiao Y; Yang QC; Bushabu Fidele N; Yu HJ; Sun ZJ
Int Immunopharmacol; 2023 Dec; 125(Pt A):111128. PubMed ID: 37907049
[TBL] [Abstract][Full Text] [Related]
3. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma.
Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H
Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
5. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
7. Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient.
Sun Y; Yang J; Cai H; Liu J; Liu Y; Luo J; Zhou H
J Oral Pathol Med; 2022 Aug; 51(7):611-619. PubMed ID: 35708285
[TBL] [Abstract][Full Text] [Related]
8. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
9. Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis.
Zi M; Xingyu C; Yang C; Xiaodong S; Shixian L; Shicheng W
Apoptosis; 2023 Apr; 28(3-4):348-361. PubMed ID: 36370260
[TBL] [Abstract][Full Text] [Related]
10. The involvement of promoter methylation and DNA methyltransferase-1 in the regulation of EpCAM expression in oral squamous cell carcinoma.
Shiah SG; Chang LC; Tai KY; Lee GH; Wu CW; Shieh YS
Oral Oncol; 2009 Jan; 45(1):e1-8. PubMed ID: 18485790
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.
Wu L; Deng WW; Yu GT; Mao L; Bu LL; Ma SR; Liu B; Zhang WF; Sun ZJ
Cancer Immunol Immunother; 2016 Sep; 65(9):1035-45. PubMed ID: 27383830
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma.
Sasaya T; Kubo T; Murata K; Mizue Y; Sasaki K; Yanagawa J; Imagawa M; Kato H; Tsukahara T; Kanaseki T; Tamura Y; Miyazaki A; Hirohashi Y; Torigoe T
Cancer Med; 2023 Feb; 12(4):4605-4615. PubMed ID: 36200687
[TBL] [Abstract][Full Text] [Related]
13. Role of epigenetics in OSCC: an understanding above genetics.
Vatsa PP; Jindal Y; Bhadwalkar J; Chamoli A; Upadhyay V; Mandoli A
Med Oncol; 2023 Mar; 40(4):122. PubMed ID: 36941511
[TBL] [Abstract][Full Text] [Related]
14. PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers.
Wu T; Tang C; Tao R; Yong X; Jiang Q; Feng C
Front Immunol; 2021; 12():693881. PubMed ID: 34552581
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
16.
Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
[TBL] [Abstract][Full Text] [Related]
17. Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cells.
Jin L; Miao J; Liu Y; Li X; Jie Y; Niu Q; Han X
Biomed Pharmacother; 2017 Jan; 85():287-295. PubMed ID: 27889233
[TBL] [Abstract][Full Text] [Related]
18. PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma.
Bhol CS; Mishra SR; Patil S; Sahu SK; Kirtana R; Manna S; Shanmugam MK; Sethi G; Patra SK; Bhutia SK
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166428. PubMed ID: 35533906
[TBL] [Abstract][Full Text] [Related]
19. Novel mucoadhesive celecoxib-loaded cubosomal sponges: Anticancer potential and regulation of myeloid-derived suppressor cells in oral squamous cell carcinoma.
Mabrouk AA; El-Mezayen NS; Tadros MI; El-Gazayerly ON; El-Refaie WM
Eur J Pharm Biopharm; 2023 Jan; 182():62-80. PubMed ID: 36513316
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells and plasmacytoid dendritic cells are associated with oncogenesis of oral squamous cell carcinoma.
Kouketsu A; Haruka S; Kuroda K; Hitoshi M; Kensuke Y; Tsuyoshi S; Takahashi T; Hiroyuki K
J Oral Pathol Med; 2023 Jan; 52(1):9-19. PubMed ID: 36380437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
